CORMEDIX INC. - COMMON
10.63
07-November-24 15:59:59
15 minutes delayed
Stocks
+0.31
+3.00%
Today's range
10.28 - 10.71
ISIN
N/A
Source
NASDAQ
-
15 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
Cormedix Inc. To Present At The Jefferies Healthcare Conference
30 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath
16 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
15 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
08 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
03 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
01 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory, Manufacturing and Reimbursement Updates
26 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors
17 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
30 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory and Manufacturing Updates
02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Promotions in Commercial and Tech Ops
17 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
10 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath
07 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
02 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference
20 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
07 Sep 2022 08:30:01 By Nasdaq GlobeNewswire
-
11 Aug 2022 07:30:01 By Nasdaq GlobeNewswire